Skip to main content

Table 1 Baseline Clinicopathologic Characteristics

From: Validation and modification of staging Systems for Poorly Differentiated Pancreatic Neuroendocrine Carcinoma

Characteristic

N = 568

No.

%

Age, years

  < 60

231

40.7

  ≥ 60

337

59.3

Sex

 Male

335

59.0

 Female

233

41.0

Race

 White

443

78.0

 Black

67

11.8

 Other

58

10.2

Year of diagnosis

 1988–1997

60

10.6

 1998–2007

187

32.9

 2008–2015

321

56.5

Location

 Head

236

41.5

 Body and tail

179

31.5

 Other*

153

27.0

ENETS stage

 I

7

1.2

 II

34

6.0

  IIA

15

2.6

  IIB

19

3.4

 III

113

19.9

  IIIA

25

4.4

  IIIB

88

15.5

 IV

414

72.9

8th AJCC stage

 I

35

6.2

  IA

8

1.4

  IB

27

4.8

 II

78

13.7

  IIA

27

4.8

  IIB

51

8.9

 III

41

7.2

 IV

414

72.9

7th AJCC stage

 I

33

5.8

  IA

8

1.4

  IB

25

4.4

 II

102

18.0

  IIA

23

4.1

  IIB

79

13.9

 III

19

3.3

 IV

414

72.9

Modified 7th stage

 I

50

8.8

  IA

9

1.6

  IB

41

7.2

 II

85

15.0

 III

19

3.3

 IV

414

72.9

  1. *Other location included overlapping lesion of pancreas and other specified parts of pancreas